Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway

Xiang Hu(Shanghai Medical College of Fudan University), San-Jun Cai(Shanghai Medical College of Fudan University)
Journal of Experimental & Clinical Cancer Research
March 1, 2018
Cited by 79


Related Papers